Data / Form D filings / Galaxy Diagnostics, Inc.
Galaxy Diagnostics, Inc.: Form D filings
Galaxy Diagnostics, Inc., a biotechnology company in Durham, NC, filed 6 Form D notices with the SEC between 2009 and 2026. The latest, on June 3, 2026, reports $3 million sold of a $5.7 million offering to 45 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 DAVIS DRIVE SUITE 832, Durham, NC, 27713
- Phone
- (919) 313-9672
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- North Carolina
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1462444
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | New notice | $5,699,460 | $3,019,645 | $2,679,815 | 45 | May 1, 2026 | sec.gov |
| Apr 22, 2025 | New notice | $11,177,342 | $4,141,184 | $7,036,158 | 55 | Apr 9, 2025 | sec.gov |
| Jul 31, 2024 | Amendment | $3,000,000 | $2,026,000 | $974,000 | 27 | Aug 11, 2023 | sec.gov |
| Jul 10, 2024 | New notice | $2,000,000 | $825,000 | $1,175,000 | 13 | Aug 11, 2023 | sec.gov |
| Aug 15, 2014 | New notice | $1,000,000 | $550,814 | $449,186 | 7 | Jul 29, 2014 | sec.gov |
| May 12, 2009 | New notice | $100,000 | $40,000 | $60,000 | 3 | Apr 22, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nicole Bell | Executive Officer, Director | |
| B. Jefferson Clark | Executive Officer, Director | |
| Richard West | Director | |
| Edward Breitschwerdt | Director | |
| Amanda Elam | Director | |
| Joel Kimbrough | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Galaxy Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.